Table 1: Number and percentage of patients with criteria fulfilled in first phase  
Criteria   Standard   Yes   No   Unknown Not indicated
1. Register   100%   349 (100%)   0 (0%)   / /

2.

BP measured at least in 2 occasions prior to commencement of drug therapy   90%   110 (31.5%)   16 (4.6%)   223 (63.9%) /
  % of cases if unknown cases excluded         87.3%     12.7%      

3.

Symptoms and signs of target organ damage assessed:   90%                  
  a. retinopathy       26 (7.4%)   177 (92.6%)   / /
  b. left ventricular hypertrophy       69 (19.8%)   280 (80.2%)   / /
  c. angina       182 (52.1%)   167 (47.9%)   / /
  d. stroke       45 (12.9%)   304 (87.1%)   / /
  e. heart failure       198 (56.7%)   151 (43.3%)   / /
  f. peripheral vascular disease       26 (7.4%)   323 (92.6%)   / /
  g. renal disease       201 (57.6%)   148 (42.4%)   / /
4. Risk factors for cardiovascular and cerebrovascular disease assessed   90%                  
  a. smoking habit       348 (99.7%)   1 (0.3%)   / /
  b. body mass index       344 (98.6%)   5 (1.4%)   / /
  c. diabetes mellitus       329 (94.3%)   33 (5.7%)   / /
  d. serum cholesterol       316 (90.5%)   33 (9.5%)   / /
  e. excessive alcohol intake       347 (99.4%)   2 (0.6%)   / /
  f. physical inactivity       285 (81.7%)   64 (18.3%)   / /
  g. family history of coronary artery disease       343 (98.3%)   6 (1.7%)   / /

5.

Pre-treatment BP > 140/90   90%   125 (35.8%)   1 (0.3%)   223 (63.9%) /
  % of cases if unknown cases excluded         99.2%     0.8%      
6. Patient reviewed at least every 6 months   90%   344 (98.2%)   5 (1.4%)   / /
7. a. Blood pressure <140/90   70%   185 (53%)   164 (47%)   / /

 

b. Blood pressure <130/80 for patients with diabetes or renal disease       17 (20%)   67 (80%)   / /

8.

Patient referred for specialist advice   90%   4 (1.1%)   3 (0.9%)   / 342 (98%)
  % if cases not indicated excluded         57.1%     42.9%      
9. Side effects of drugs assessed annually   80%   275 (78.8%)   74 (11.2%)   / /
10. Diet advice given annually   80%   237 (67.9%)   112 (22.1%)   / /